Segments-
For the purpose of this study, Market Research Future has segmented the market of wireless audio device into type, service provider and region.
Product –
• Wireless Speaker System
• Wireless Headsets
• Sound Bar
• Wireless Microphones
Technology –
• Bluetooth
• Wi-Fi
• Airplay
• Others
End-User –
• Commercial
• Electronics
• Telecommunications
• Automotive
• Security & Defiance
Region
• North-America
• Europe
• Asia-Pacific
• RoW

Key Players
Some of the major players in global wireless audio device market include Sony Corporation (Japan), Bose Corporation (U.S.), Sennheiser Electronic Gmbh & Company Kg (Germany), LG Electronics (South Korea), Sonos, Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), Vizio Holdings, Inc. (U.S.), Apple Inc. (U.S.), Voxx International Corporation (U.S.), and Samsung Electronics Co., Ltd (South Korea).
Regional Analysis-
North America is dominating the wireless audio device market, and is followed by Asia-Pacific and Europe. The availability of low cost of consumer equipment and growth of smart phones, are the growth drivers of wireless audio device market in North America. Among North America region, the U.S., is the leading economy in wireless audio device market and is expected to grow with a CAGR of more than 16% during the forecast period of 2016-2027, while Asia-Pacific region is expected to grow with a highest rate due to growing advancement in the technology as well as due to the growing demand and adoption of smartphones in the region.
By Region, North America is dominating the wireless audio device market with ~ 46% market share whereas, Europe and Rest of the World have held 28% and 8% of market share, respectively in 2016. Asia-Pacific has been the fastest growing region in wireless audio device market, due to the growing technological advancement in the region, thereby having ~19% of market in 2016.
In addition, North America has dominated the global wireless audio device market, generating USD 5.74 billion of market value in 2016 and is expected to reach USD 34.61 billion by the end of 2027, with growing 17.74% CAGR. It was followed by Europe, which is expected to generate USD 14.73 billion market by 2027. However, Asia-Pacific is projected to be the fastest growing market with 20.53% CAGR and is estimated to generate market value of USD 18.10 billion, by 2027. However, rest of the world is growing with a CAGR of 10.67% CAGR over the forecast period, 2016-2027.
Key Findings-
• The global wireless audio device market is expected to reach USD 70 billion by 2027, growing with approximately 17% CAGR during forecast period, 2016-2027.
• By Product, Wireless speaker systems are dominating the market and has generated USD 4.48 billion in 2016, whereas, Sound bar is expected to grow with fastest growing 21.37 % CAGR.
• By Technology, Bluetooth technology is dominating the market and is expected to generate value of USD 36.46 billion by 2027, growing with 18.95% CAGR.
• North America is expected to dominate the wireless audio device market, throughout the forecast period.

1 Executive Summary
2 Market Dynamics
2.1 Market Drivers
2.2 Market Inhibitors
2.3 Supply Chain Analysis
2.4 Porter’s Five Forces Analysis

3 Global Wireless Audio Device Market, By Product
3.1 Introduction
3.2 Market by Sub-segment
3.2.1 Wireless Speaker System
3.2.2 Wireless Headsets
3.2.3 Sound Bar
3.2.4 Wireless Microphones

4 Global Wireless Audio Device Market, By Technology
4.1 Introduction
4.2 Market by Sub-Segment
4.2.1 Bluetooth
4.2.2 Wi-Fi
4.2.3 Airplay
4.2.4 Others

5 Global Wireless Audio Device Market, By End-User
5.1 Introduction
5.2 Market by Sub-segment
5.2.1 Commercial
5.2.2 Electronics
5.2.3 Telecommunications
5.2.4 Automotive
5.2.5 Security & Defence

6 Global Wireless Audio Device Market, By Region
6.1 Introduction
6.2 Market by Sub-segment
6.2.1 North America
6.2.2 Europe
6.2.3 Asia-Pacific
6.2.4 Rest of the world (ROW)

7 Competitive Landscape
7.1 Introduction
7.2 Competitive Scenario
7.3 Market Share Analysis
7.4 Company Profiles

7.4.1 Sony Corporation
7.4.1.1 Company Overview
7.4.1.2 Product/Services Offering
7.4.1.3 Business Strategy
7.4.1.4 SWOT Analysis

7.4.2 Bose Corporation
7.4.2.1 Overview
7.4.2.2 Product/Services Offering
7.4.2.3 Business Strategy
7.4.2.4 SWOT Analysis

7.4.3 Koninklijke Philips N.V.
7.4.3.1 Company Overview
7.4.3.2 Product/Services Offering
7.4.3.3 Business Strategy
7.4.3.4 SWOT Analysis

7.4.4 Apple, Inc.
7.4.4.1 Company Overview
7.4.4.2 Product/Services Offering
7.4.4.3 Strategy
7.4.4.4 SWOT Analysis

7.4.5 Samsung Electronics
7.4.5.1 Company Overview
7.4.5.2 Product/Services Offering
7.4.5.3 Strategy
7.4.5.4 SWOT Analysis

7.4.6 LG Electronics
7.4.6.1 Company Overview
7.4.6.2 Product/Services Offering

7.4.7 Vizio Holdings Inc.
7.4.7.1 Company Overview
7.4.7.2 Product/Services Offering

7.4.8 Sennheiser Electronics GmbH & Company Kg
7.4.8.1 Company Overview
7.4.8.2 Product / Service Offering
7.4.9 Sonos Inc.
7.4.9.1 Overview
7.4.9.2 Product/Services Offering

7.4.10 Voxx International Corporation
7.4.10.1 Company Overview
7.4.10.2 Product/Services Offering

8 Appendix:
8.1 Scope of the Study
8.1.1 Research Objective
8.1.2 Assumption
8.1.3 Limitation
8.2 Market Structure
9 Research Methodologies
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
9.4 Market Size Estimation
9.5 Forecast Model

The post Global Wireless Audio Device Market Research Report – Forecast to 2027 first appeared on CRI Report.

The global cancer biological therapy market is expected to reach USD 82,276.8 million by 2023 at a CAGR of 4.7% during the forecasted period.
The global cancer biological therapy market is segmented on the basis of phases, types, end users and regions. On the basis of phases, the market is segmented into phase I, phase II and phase III. In stage I & II the real impact of these therapies is seen and giving a success rate of 35% in Phase 1 and 20% in Phase II. The success rate of phase I is 35%.
On the basis on types, the global cancer biological therapy market is segmented into monoclonal antibodies, cancer growth blockers, interferons, interleukins, gene therapy, targeted drug delivery, colony stimulating factor, cancer vaccines and others. Monoclonal antibodies accounted for the largest market share of the global cancer biological therapy market. Colony stimulating factor is the fastest growing market at a CAGR of 5.2% during the forecasted period.
On the basis on end users, hospitals & clinics dominates the global cancer biological therapy market. Registering USD 26,790.6 million in 2016 and expected to reach at USD 38,471.9 million by 2023 at the rate of 4.4 % from 2016-2023.
On the basis of regions, the market is segmented into North America, Europe, Asia-Pacific and the Middle East & Africa. North America has the dominating market for cancer biological therapy. The cancer biological therapy market for North America is estimated at USD 19,481.2 million in 2016 and expected to reach by USD 29,516.9 million by 2023 at a fastest CAGR of 5.10%.

Key Players
The leading market players in the global cancer biological therapy market include Merck Inc., F. Hoffmann-La Roche Ltd, Novartis AG, Amgen Inc., Bristol-Myers Squibb, Celgene, ELI Lilly and Company, EnGeneIC, and Pfizer
Study objectives
• To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of the global cancer biological therapy market
• To provide insights about factors influencing and affecting the market growth
• To provide historical and forecast revenue of the market segments and sub-segments with respect to countries
• To provide historical and forecast revenue of the market segments based on channels, applications, and regions for the global cancer biological therapy market.
• To provide strategic profiling of key players in the market, and comprehensively analysing their market share, core competencies, and drawing a competitive landscape for the market
• To provide economical factors that influences the global cancer biological therapy market
• To provide detailed analysis of the value chain and supply chain of the global cancer biological therapy market
Target Audience
• Pharmaceutical Companies
• Pharmaceutical Suppliers
• Cancer Research Organizations
• Potential Investors
• Key Executive (CEO and COO) and Strategy Growth Manager
• Reaserch Companies
Key Findings
• North America accounted for the largest market share in the global cancer biological therapy market, USD 19,481.2 million in 2016 and expected to reach by USD 29,516.9 million by 2023 at a fastest CAGR of 5.10%
• Colony stimulating factor is the fastest growing segment with a CAGR of and 5.2% in the global cancer biological therapy market, by types
• Hospitals and clinics is contributing remarkable share in the market registering 47.8% in the global cancer biological therapy market, by end users in 2016

The reports also covers regional analysis
• North America
o US
o Canada
• Europe
o Germany
o France
o U.K.
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Republic of Korea
o Rest of Asia-Pacific
• Middle East & Africa
o Middle East
o Africa

1 Report Prologue
2 Market Introduction
2.1 Definition
2.2 Scope of Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
2.5 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing Cancer Survival Rate
4.2.2 Growing Demand for Advanced Therapies
4.2.3 Less Number of Side Effects as Compared to Conventional Treatment Methods
4.2.4 Growth of Cancer Healthcare Facilities in Emerging Countries
4.2.5 Changing Lifestyle and Increasing Smoking Population in Middle East & Africa
4.3 Restraints
4.3.1 High cost of Cancer Biological Therapy
4.4 Opportunities
4.4.1 UnTapped Types of Cancers
5 Market Factor Analysis
5.1 Porter’s Five Forces Model
5.1.1 Bargaining power of suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
6 Global Cancer Biological Therapy Market, by phases
6.1 Introduction
6.2 Phases
7 Global Cancer Biological Therapy Market, by Application
7.1 Introduction
7.2 Monoclonal Antibodies
7.3 Interferons
7.4 Interleukins
7.5 Cancer growth inhibitors
7.6 Gene Therapy
7.7 Colony-Stimulating Factors
8 Global Cancer Biological Therapy Market, by End Users
8.1 Introduction
8.2 Hospitals & Clinics
8.3 Cancer Research Centers
8.4 Laboratories
9 Global Cancer Biological Therapy Market, by Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 U.K.
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Republic of Korea
9.4.5 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa
12 Competitive Landscape
12.1 Company Share Analysis
13 Company Profiles
13.1 Amgen Inc.
13.1.1 Company Overview
13.1.2 Product/Business Overview
13.1.3 Adherium Health: Financials
13.1.4 Key Developments
13.1.5 SWOT Analysis
13.2 Bristol-Myers Squibb
13.2.1 Company Overview
13.2.2 Product overview
13.2.3 Financial Overview
13.2.4 Key Developments
13.2.5 SWOT Analysis
13.3 Celgene Corporation
13.3.1 Company Overview
13.3.2 Product Overview
13.3.3 Financial Overview
13.3.4 Key Development
13.3.5 SWOT Analysis
13.4 ELI Lilly and Company
13.4.1 Company Overview
13.4.2 Product Overview
13.4.3 Financial Overview
13.4.4 Key Developments
13.4.5 SWOT Analysis
13.5 EnGeneIC Ltd
13.5.1 Company Overview
13.5.2 Product overview
13.5.3 Financial Overview
13.5.4 Key Developments
13.5.5 SWOT Analysis

The post Global Cancer Biological Theraphy Market Research Report- Forecast to 2023 first appeared on CRI Report.

The total muscle stimulator market is expected to reach USD 768.3 million by 2023 at a CAGR of 6.1% during the forecasted period.
The global muscle stimulator market is segmented on the basis of products, applications. The global muscle stimulator market by products is divided into Transcutaneous Electrical Nerve Stimulator, Burst mode Alternating Current, Neuromuscular Electric Stimulation, Interferential Current. Transcutaneous Electrical Nerve Stimulator market is commanding the largest market share of 34.0% in 2016, this market is expected to reach USD 268.5 million in 2023 for USD 174.4 million in 2016 at a CAGR of 6.6% during forecast period.

Global muscle stimulator Market by application comprises of Pain Management, Neurological and Movement Disorder Management and Musculoskeletal Disorder Management. Out of which Pain Management application holds the largest market share of 46.6% in 2016, this market is expected to reach US$ 366.2 million in 2023 from US$ 238.5 million in 2016 and is growing at a stable CAGR of 6.4% globally.

On the basis of region the global Muscle Stimulator market is segmented into North America, Europe, Asia Pacific, Middle East & Africa. North America is commanding the largest market share of 41.6% in 2016 with countries like US and Canada playing a prominent role in the development of the market. US market is expected to reach US$ 265.8 million in 2023 from US$ 166.7 million in 2016, this market is expected to grow at a CAGR of 7.0% during the forecast period 2017-2023. Asia-Pacific is the fastest growing market and is expected to grow at a CAGR of 6.6% during forecasted period
Key Players
The leading market players in the global muscle stimulator market include DJO Global, Inc., Mettler Electronics Corp., Axiobionics, Zynex, NeuroMetrix, Inc., OMRON Corporation, Tone-A-Matic and others.
Study objectives
• To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of the global muscle stimulator market
• To provide insights about factors influencing and affecting the market growth
• To provide historical and forecast revenue of the market segments and sub-segments with respect to countries
• To provide historical and forecast revenue of the market segments based on products, applications, and regions for the global muscle stimulator market.
• To provide strategic profiling of key players in the market, and comprehensively analysing their market share, core competencies, and drawing a competitive landscape for the market
• To provide economic factors that influences the global muscle stimulator market
• To provide detailed analysis of the value chain and supply chain of the global muscle stimulator market

Target Audience
• Pharmaceutical Companies
• Pharmaceutical Suppliers
• Potential investors
• Key executive (CEO and COO) and strategy growth manager
• Reaserch companies
Key Findings
• The muscle stimulator global market and is expected to reach USD 768.3 million by 2023
• Transcutaneous Electrical Nerve Stimulator market is commanding the largest market share of 34.0% in 2016.
• North America holds the largest market share of 41.6% of microfluidic devices market and is anticipated to reach USD 328.9 million by the end of forecast period
• Asia the fastest growing region and expected to grow at the CAGR of 6.6% during the forecast period
The reports also covers regional analysis
• North America
o US
o Canada
• Europe
o Germany
o France
o U.K.
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Republic of Korea
o Rest of Asia-Pacific
• Middle East & Africa
o Middle East
o Africa

1Report Prologue
2Market Introduction
2.1Introduction
2.2Scope of The Study
2.2.1Research Objectives
2.2.2Assumptions
2.2.3Limitations
2.3Market Structure
3Research Methodology
3.1Introduction
3.2Primary Research
3.3Secondary Research
4Market Dynamics
4.1Drivers
4.1.1Increasing Popularity of Sports and Increased Demand for Fitness Products
4.1.2Ageing Population
4.1.3Increasing Healthcare Expenditure and Rising Affordability of Muscle Stimulators
4.1.4Increasing Incidence of Muscle Diseases and Disorders
4.1.5Demand for Non-Invasive Technology Devices and Growing Preference for Muscle Stimulators Among Physiotherapists
4.2Restraints
4.2.1Alternative Therapies
4.2.2Lack of Usage Guidelines and Safety Concerns
4.2.3Regulatory Uncertainties in the US
4.3Opportunities
4.3.1Research and Development
4.3.2Personalization and customization
4.4Challenges
4.4.1Market Fragmentation and Falling Profit Margin
4.4.2Spurious Low Quality Products
4.5Macroeconomic Indicators
4.5.1Electronics Manufacturing of Medical Devices has Good Growth Despite Poor Performancby Electronics Manufacturing as a Whole
4.5.2Growth of Contract Manufacturing in Medical Devices Especially Muscle Stimulators
4.5.3Rise of Developing Regions in Muscle Stimulator Market
4.6Mega Trends In Muscle Stimulators
4.6.1Smart and Connected Muscle Stimulators Products
4.6.2Green Electronics Manufacturing for Muscle Stimulators
4.6.3Energy-Efficient Muscle Stimulators and Safety
5Market Factor Analysis
5.1Porter’s Five Force Analysis
5.1.1Threat from a New Entrant
5.1.2Bargaining Power of Buyer
5.1.3Bargaining Power of Supplier
5.1.4Threat from Substitute
5.1.5Intensity of Competitive Rivalry
5.2Supply Chain Analysis
5.2.1Raw Material
5.2.2Supplier
5.2.3Poor Integration of Supplier in the Supply Chain
5.2.4Manufacturer
5.2.5Distributer
5.2.6Customer
5.2.7Consumer
5.3Investment Feasibility Analysis
5.4Pestle Analysis
5.4.1Political
5.4.2Economic
5.4.3Social
5.4.4Technological
5.4.5Legal
5.4.6Environmental
6Global Muscle Stimulator Test Market, By Product
6.1Introduction
6.2Transcutaneous Electrical Nerve Stimulator
6.3Burst mode Alternating Current
6.4Neuromuscular Electric Stimulation
6.5Interferential Current
7Global Muscle Stimulator Test Market By Application
7.1Introduction
7.2Pain Management
7.3Neurological and Movement Disorder Management
7.4Musculoskeletal Disorder Management
8Global Muscle Stimulator Test Market, By Regions
8.1Introduction
8.2North America
8.2.1US
8.2.2Canada
8.3Europe
8.3.1Germany
8.3.2France
8.3.3UK
8.3.4Italy
8.3.5Spain
8.3.6Rest of Europe
8.4Asia Pacific
8.4.1Japan
8.4.2China
8.4.3India
8.4.4Republic of Korea
8.4.5Australia
8.4.6Rest of Asia Pacific
8.5Middle East & Africa
8.5.1UAE
8.5.2Saudi Arabia
8.5.3Egypt
8.5.4Rest of Middle & Africa
9Competitive Landscape
9.1Introduction
9.2Market Share Analysis
9.3Key Development & Strategies
10Company Profile
10.1DJO Global, Inc.
10.1.1Company Overview
10.1.2Product Overview
10.1.3Financial Overview
10.1.4SWOT ANALYSIS
10.2Mettler Electronics Corp.
10.2.1Company Overview
10.2.2Product Overview
10.2.3Financial Overview
10.2.4SWOT ANALYSIS
10.3Axiobionics
10.3.1Company Overview
10.3.2Product Overview
10.3.3Financial Overview
10.3.4Key Developments
10.3.5SWOT ANALYSIS
10.4Zynex
10.4.1Company Overview
10.4.2Product/Business Segment Overview
10.4.3Financial Overview
10.4.4Key Development
10.4.5SWOT ANALYSIS
10.5NeuroMetrix, Inc.
10.5.1Company Overview
10.5.2Product Overview
10.5.3Financial Overview
10.5.4Key Development
10.5.5SWOT ANALYSIS
10.6Omron Corporation
10.6.1Company Overview
10.6.2Product Overview
10.6.3Financial Overview
10.6.4Key Developments
10.6.5SWOT ANALYSIS
10.7Tone-A-Matic
10.7.1Company Over
10.7.2Product Overview
10.7.3Financial Overview
10.7.4SWOT ANALYSIS
11Conclusion
11.1Key Findings
11.1.1From CEO’s View Point
11.1.2Key Companies to Watch
12Appendix
12.1Discussion Blue Print

The post Global Muscle Stimulators Market Research Report – Forecast to 2023 first appeared on CRI Report.